Marshall Wace North America’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-108,059	Closed	-$6.65M	–	1561
2021 Q1	$6.65M	Buy	+108,059	New	+$6.65M	0.03%	490